Injectable drugs require refrigeration when they are stored or transported, and the pill potentially opens up the market

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged in popularity for this purpose around the world.